Global Medical REIT (NASDAQ:GMRE) Receiving Somewhat Favorable Press Coverage, Study Finds

News coverage about Global Medical REIT (NASDAQ:GMRE) has trended somewhat positive on Friday, according to Accern. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Global Medical REIT earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.1825871900876 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

A number of equities analysts recently commented on the stock. Zacks Investment Research raised shares of Global Medical REIT from a “sell” rating to a “buy” rating and set a $11.00 price objective for the company in a research note on Wednesday, May 10th. TheStreet raised shares of Global Medical REIT from a “d” rating to a “c-” rating in a research note on Monday, July 10th. Finally, FBR & Co reaffirmed an “outperform” rating and set a $10.00 price target on shares of Global Medical REIT in a research report on Tuesday, July 11th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Global Medical REIT presently has a consensus rating of “Buy” and an average target price of $10.67.

Global Medical REIT (NASDAQ:GMRE) traded up 2.39% on Friday, hitting $8.99. 70,788 shares of the company traded hands. The stock’s 50-day moving average is $9.16 and its 200 day moving average is $9.04. Global Medical REIT has a 12 month low of $6.73 and a 12 month high of $11.24.

Global Medical REIT (NASDAQ:GMRE) last announced its quarterly earnings results on Thursday, August 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by $0.17. Global Medical REIT had a negative net margin of 54.55% and a negative return on equity of 6.70%. The business had revenue of $7.42 million during the quarter, compared to analysts’ expectations of $6.16 million. Equities analysts predict that Global Medical REIT will post ($0.09) earnings per share for the current year.

In other Global Medical REIT news, Chairman Jeffrey Busch purchased 11,100 shares of Global Medical REIT stock in a transaction on Friday, June 30th. The shares were bought at an average price of $9.00 per share, with a total value of $99,900.00. Following the completion of the acquisition, the chairman now directly owns 20,110 shares of the company’s stock, valued at $180,990. The transaction was disclosed in a document filed with the SEC, which is available through this link.

TRADEMARK VIOLATION WARNING: “Global Medical REIT (NASDAQ:GMRE) Receiving Somewhat Favorable Press Coverage, Study Finds” was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at

About Global Medical REIT

Global Medical REIT Inc focuses on operating as a real estate investment trust. The Company is engaged primarily in the acquisition and leasing of licensed purpose-built healthcare facilities in certain markets with various clinical operators. The Company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals and outpatient treatment centers.

What are top analysts saying about Global Medical REIT Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Global Medical REIT Inc and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit